Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility
about
A research agenda for helminth diseases of humans: intervention for control and eliminationGlobal functional analyses of cellular responses to pore-forming toxinsStructure and Glycolipid Binding Properties of the Nematicidal Protein Cry5BBacillus thuringiensis-derived Cry5B has potent anthelmintic activity against Ascaris suumDiethylcarbamazine increases activation of voltage-activated potassium (SLO-1) currents in Ascaris suum and potentiates effects of emodepsideThe novel nematicide wact-86 interacts with aldicarb to kill nematodes.Caenorhabditis elegans-based model systems for antifungal drug discovery.The pore-forming protein Cry5B elicits the pathogenicity of Bacillus sp. against Caenorhabditis elegans.Schistosome ABC multidrug transporters: From pharmacology to physiology.Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.Effect of combinations of marketed human anthelmintic drugs against Trichuris muris in vitro and in vivoABC multidrug transporters in schistosomes and other parasitic flatwormsBacillus subtilis strain engineered for treatment of soil-transmitted helminth diseasesMicrofluidics-enabled method to identify modes of Caenorhabditis elegans paralysis in four anthelmintics.Bacterial pore-forming proteins as anthelmintics.Nitazoxanide: nematicidal mode of action and drug combination studies.Current drug targets for helminthic diseases.Intracellular and Extracellular Expression of Bacillus thuringiensis Crystal Protein Cry5B in Lactococcus lactis for Use as an Anthelminthic.Update on prevention and treatment of intestinal helminth infections.Drug Discovery in Fish, Flies, and Worms.Anthelmintic resistance in gastrointestinal nematodes of beef cattle in the state of Rio Grande do Sul, Brazil.Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique.Genetic and Biochemical Characterization of a Gene Operon for trans-Aconitic Acid, a Novel Nematicide from Bacillus thuringiensis.In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasitesBacillus thuringiensis Cry5B protein as a new pan-hookworm cure.Hookworm infection
P2860
Q21562256-30024479-A95B-4EE4-9063-F5D8D87385CCQ27312103-59A4D7EE-00DD-40A3-B912-8E45459499FAQ27675127-50A1CAE4-2163-4D7D-BF1C-AEB2C427D992Q28534011-6C3142F1-58D8-4B81-9C46-58D37E820883Q28545077-6FF32417-C524-4081-A240-7C130BB4ACDFQ33570926-CDA1DF8A-8754-40FD-B7CB-96645BB51A5FQ33864072-B2D59D14-C1E9-474D-A690-4A41120C0562Q34117229-220AA249-047F-4561-9783-F0BEE2426A7AQ34705514-7B0F0CCB-EEAF-45DA-8A97-4F188DE5E15FQ36296803-AECC07C5-232F-471D-9C3A-E6B355CA980AQ36499326-F5584EDE-A2BA-412F-B09F-CBE97FDFAD47Q37053762-DAEEC098-CBED-43D2-8CCE-CC1DB42BE00DQ37123637-B1E4C56B-A7BD-4FB5-BACA-0CA087B65B77Q37337055-A8CD2FE7-C0A0-4250-A44D-06C19924A1A9Q37469105-0783B6D1-477A-481A-B2E4-ED9778E9542AQ37678601-DB52DCE4-850D-41D5-9B73-6A98EE21247AQ38093067-898A9AE5-D25D-4D39-95AC-3239E5BEEC5DQ38386911-C322783C-AC72-4D89-A858-A7631D00AF23Q38395403-30A527E4-28EF-467B-87B2-9C8478187648Q39039978-D3862173-A07B-41C2-A892-41BDEC28020BQ39432504-6C772209-8D5E-486D-8C50-B552B158F639Q41815282-3385CE56-73E6-4BA9-967A-78ED9D573EF4Q51191285-22444B25-130C-4124-ABE4-2C1F58A50FD0Q54157122-3D1A8C18-BAA0-4109-BADE-11FC326B0EF2Q54208548-3B5BF4F7-2CC7-461E-A4FB-769FF211FB76Q57964233-A4D490CE-FCD3-46D4-94A2-BBE587A60593
P2860
Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery of a highly synergis ...... ows mutual hypersusceptibility
@ast
Discovery of a highly synergis ...... ows mutual hypersusceptibility
@en
type
label
Discovery of a highly synergis ...... ows mutual hypersusceptibility
@ast
Discovery of a highly synergis ...... ows mutual hypersusceptibility
@en
prefLabel
Discovery of a highly synergis ...... ows mutual hypersusceptibility
@ast
Discovery of a highly synergis ...... ows mutual hypersusceptibility
@en
P2093
P2860
P356
P1476
Discovery of a highly synergis ...... ows mutual hypersusceptibility
@en
P2093
Edward G Platzer
Raffi V Aroian
P2860
P304
P356
10.1073/PNAS.0912327107
P407
P577
2010-03-15T00:00:00Z